UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience

Diabetologia, 2012-06, Vol.55 (6), p.1641-1650

2012

Volltextzugriff (PDF)

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

European heart journal, 2014-08, Vol.35 (32), p.2146-2157

2014

Volltextzugriff (PDF)

Insulin resistance and cardiovascular disease

The Journal of clinical investigation, 2000-08, Vol.106 (4), p.453-458

Ginsberg, H N

2000

Volltextzugriff (PDF)

Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells

Journal of lipid research, 1993-02, Vol.34 (2), p.167-179

1993

Volltextzugriff (PDF)

Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1

Arteriosclerosis, thrombosis, and vascular biology, 1998-03, Vol.18 (3), p.441-449

1998

Volltextzugriff (PDF)

LIPOPROTEIN PHYSIOLOGY

Endocrinology and metabolism clinics of North America, 1998-09, Vol.27 (3), p.503-519

Ginsberg, Henry N.

1998

Volltextzugriff (PDF)

Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels

Diabetes (New York, N.Y.), 1996-07, Vol.45 Suppl 3 (Supplement_3), p.S27-S30

Ginsberg, H N

1996

Volltextzugriff (PDF)

Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance

Diabetes, obesity & metabolism, 2001-10, Vol.3 (5), p.360-366

2001

Volltextzugriff (PDF)

Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B

The Journal of biological chemistry, 1991-03, Vol.266 (8), p.5080-5086

1991

Volltextzugriff (PDF)

Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial

Journal of Alzheimer's disease, 2021-01, Vol.83 (4), p.1703-1715

2021

Volltextzugriff (PDF)

Effects of Statins on Triglyceride Metabolism

The American journal of cardiology, 1998-02, Vol.81 (4), p.32B-35B

Ginsberg, Henry N

1998

Volltextzugriff (PDF)

Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis

Diabetes care, 1991-09, Vol.14 (9), p.839-855

Ginsberg, H N

1991

Volltextzugriff (PDF)

Nonpharmacologic management of low levels of high-density lipoprotein cholesterol

The American journal of cardiology, 2000-12, Vol.86 (12), p.41-45

Ginsberg, Henry N

2000

Volltextzugriff (PDF)

Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells

The Journal of biological chemistry, 1993-11, Vol.268 (31), p.22967-22970

1993

Volltextzugriff (PDF)

Mechanism of hypertriglyceridemia in human apolipoprotein (Apo) CIII transgenic mice : diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

The Journal of clinical investigation, 1992-11, Vol.90 (5), p.1889-1900

1992

Volltextzugriff (PDF)

Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells

The Journal of biological chemistry, 1992-11, Vol.267 (31), p.22630-22638

1992

Volltextzugriff (PDF)

Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production

Journal of lipid research, 1990-04, Vol.31 (4), p.567-582

1990

Volltextzugriff (PDF)

Is hypertriglyceridemia a risk factor for atherosclerotic cardiovascular disease? A simple question with a complicated answer

Annals of internal medicine, 1997-06, Vol.126 (11), p.912

Ginsberg, H N

1997

Volltextzugriff (PDF)

HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects

The American journal of clinical nutrition, 1999-12, Vol.70 (6), p.992-1000

1999

Volltextzugriff (PDF)

Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women

Arteriosclerosis, thrombosis, and vascular biology, 1995-11, Vol.15 (11), p.1829-1838

1995

Volltextzugriff (PDF)

Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice

The Journal of clinical investigation, 1994-04, Vol.93 (4), p.1683-1690

1994

Volltextzugriff (PDF)

HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlipidemia

Nature medicine, 2001-12, Vol.7 (12), p.1327-1331

2001

Volltextzugriff (PDF)

Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol

The Journal of clinical investigation, 1993-04, Vol.91 (4), p.1743-1752

1993

Volltextzugriff (PDF)

Lipoprotein metabolism and its relationship to atherosclerosis

The Medical clinics of North America, 1994-01, Vol.78 (1), p.1-20

Ginsberg, Henry N.

1994

Volltextzugriff (PDF)

1 – 25 von 543

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(497)
Mit Volltextzugriff
(443)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Insulin resistance and cardiovascular disease

Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells

Effects of reducing dietary saturated fatty acids on plasma lipids and lipoproteins in healthy subjects: the DELTA Study, protocol 1

LIPOPROTEIN PHYSIOLOGY

Diabetic dyslipidemia: basic mechanisms underlying the common hypertriglyceridemia and low HDL cholesterol levels

Overexpression of the A1 adenosine receptor in adipose tissue protects mice from obesity-related insulin resistance

Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B

Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial

Effects of Statins on Triglyceride Metabolism

Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis

Nonpharmacologic management of low levels of high-density lipoprotein cholesterol

Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells

Mechanism of hypertriglyceridemia in human apolipoprotein (Apo) CIII transgenic mice : diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles

Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells

Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production

Is hypertriglyceridemia a risk factor for atherosclerotic cardiovascular disease? A simple question with a complicated answer

HDL-subpopulation patterns in response to reductions in dietary total and saturated fat intakes in healthy subjects

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Association of postprandial triglyceride and retinyl palmitate responses with newly diagnosed exercise-induced myocardial ischemia in middle-aged men and women

Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice

HIV protease inhibitors protect apolipoprotein B from degradation by the proteasome: A potential mechanism for protease inhibitor-induced hyperlipidemia

Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol

Lipoprotein metabolism and its relationship to atherosclerosis

Suchergebnisse filtern